Status:
UNKNOWN
Evaluation of MHP 3.0 in Two Clinical Settings
Lead Sponsor:
Naima Health LLC
Collaborating Sponsors:
University of Pittsburgh
Obstetrix Medical Group
Conditions:
Telemedicine
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to assess the acceptability and feasibility of the use of MyHealthyPregnancy (MHP) 3.0 in clinical practice over a 1 year period of time. The investigators will pilot MHP ...
Detailed Description
For this study the investigators pilot MHP products in two clinical settings to determine their acceptability and feasibility in clinical practice. The investigators will pilot MHP 3.0 (Spanish and En...
Eligibility Criteria
Inclusion
- Is at least 18 years of age
- Currently pregnant and in gestational week 12 or less
- Is under the care of a participating provider/clinic
- Owns a smartphone
- Spanish or English native speaker
Exclusion
- Under 18 years of age
- Not pregnant at time of enrollment
- Is pregnant but over 12 weeks of gestational age
- Provider is not part of the study
- Does not own a smartphone
- Native language is not Spanish or English
Key Trial Info
Start Date :
June 20 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2023
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04863521
Start Date
June 20 2022
End Date
March 31 2023
Last Update
August 12 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Obstetrix Medical Center Houston
Houston, Texas, United States, 77477